Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses

  • 0Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Centre for Psychiatric Neuroscience, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland. nermine.laaboub@gmail.com.

|

|

Summary

This summary is machine-generated.

Random caffeine metabolic ratios (CMR) effectively measure cytochrome P450 (CYP) 1A2 activity, aiding in personalized clozapine dosing and identifying patients at risk for hospital admission. This simple method offers valuable insights into drug metabolism.

Area Of Science

  • Pharmacogenomics
  • Metabolomics
  • Clinical Pharmacology

Background

  • Cytochrome P450 (CYP) 1A2 activity is crucial for metabolizing antipsychotics like clozapine and olanzapine.
  • Caffeine metabolic ratios (CMR) from monitored intake are the gold standard for assessing CYP1A2 activity.
  • Dietary caffeine offers a ubiquitous source for potential random CMR assessment.

Purpose Of The Study

  • To investigate associations between random CMR and factors influencing CYP1A2 activity.
  • To determine if random CMR correlates with clozapine and olanzapine plasma concentrations.
  • To explore the relationship between random CMR and psychotropic treatment response, including hospitalization risk.

Main Methods

  • Analysis of two population-based studies (CoLaus|PsyCoLaus, N=4898; SKIPOGH, N=2054) for random CMR associations with clinical, genetic, and epigenetic factors.
  • Testing CMR associations with dose-normalized clozapine (N=164) and olanzapine (N=222) plasma concentrations in psychiatric cohorts.
  • Evaluating CMR associations with hospital admission risk (N=1019) and prolonged psychiatric stays (N=1349).

Main Results

  • Random CMR positively correlated with age, CYP1A2 inducers (e.g., smoking), and negatively with female sex.
  • CMR negatively associated with clozapine dose-normalized concentrations, explaining 14.9% of variance, exceeding genetic factors.
  • Increased CMR linked to higher hospital admission likelihood (26%) and reduced short-stay probability (11%).

Conclusions

  • Random CMR is a practical method to assess CYP1A2 activity.
  • Random CMR can contribute to personalized clozapine dosing and identify patients at risk for adverse psychiatric outcomes.
  • Routine random CMR measurement before clozapine initiation could facilitate early CYP1A2 activity assessment for tailored dosing.

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance 01:23

642

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...

Combination Therapies and Personalized Medicine 02:50

5.9K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08

257

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...